Home > Healthcare > Medical Devices > Diagnostic Devices > D-dimer Testing Market

D-dimer Testing Market Share

Report ID: GMI5972
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

D-dimer Testing Market Share

Some of the notable key industry players operating in the d-dimer testing market include :

Abbott Laboratories
BioMedica Diagnostics
biomérieux SA
Diazyme Laboratories Inc. (General Atomics)
FHoffmann-La Roche Ltd.
HORIBA Ltd.
Quidel Corporation
Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.)
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Unbound Medicine Inc
Werfen

These market participants are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen testing method offerings as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for d-dimer testing was over USD 1 billion in 2022 and will reach more than USD 2 billion by 2032.

The enzyme-linked immunosorbent assay (ELISA) segment will record more than USD 700 million by 2032 as they are highly sensitive and capable of detecting even low levels of D-dimer in blood samples.

The U.S. d-dimer testing industry accounted for more than USD 450 billion in 2022 and will grow to USD 615 billion by 2032 owing to the affordability of d-dimer testing among the target population base and ongoing technological developments.

Abbott Laboratories, BioMedica Diagnostics, biomérieux SA, Diazyme Laboratories Inc. (General Atomics), F. Hoffmann-La Roche Ltd., HORIBA Ltd., Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Chemical Co. Ltd.), Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc.